Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Medical / Pharmaceuticals

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 1

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution
CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution
1/19/2018 9:55:20 AM
Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (CBMG or the Company), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer, has announced its plan to configure part of its facility in Shanghai with GE Healthcare’s FlexFactory™ platform, which will be designed to speed up manufacturing timelines for its cell therapy clinical …
Exciting New Technology is Coming to Marshall Tulsa Chiropractic in 2018
Exciting New Technology is Coming to Marshall Tulsa Chiropractic in 2018
1/18/2018 7:00:00 AM
Exciting new technology is coming to Marshall Tulsa Chiropractic in 2018.    All things seem to be turning digital.  This January our office will add a brand new digital x-ray system.
Toray and 3SBio Reach Exclusive Chinese License Agreement on Antipruritic Agent, TRK-820
Toray and 3SBio Reach Exclusive Chinese License Agreement on Antipruritic Agent, TRK-820
1/16/2018 9:41:49 AM
Toray Industries, Inc. (head office: Chuo-ku, Tokyo; President Akihiro Nikkaku; hereinafter referred to as “Toray”) and 3SBio Inc. (head office: Shenyang; Chairman & CEO: Jing Lou: hereinafter referred to as “3SBio”) announced that Toray and 3SBio’s wholly-owned subsidiary, Hongkong Sansheng Medical Limited (“Hongkong Sansheng”), entered into an exclusive licensing agreement …
Novartis appoints Elizabeth Barrett as Oncology Head
Novartis appoints Elizabeth Barrett as Oncology Head
1/15/2018 12:29:35 PM
Novartis announced today that Elizabeth (Liz) Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the Executive Committee of Novartis, effective February 1, 2018.
Lynparza approved by US FDA in germline BRCA-mutated metastatic breast cancer
Lynparza approved by US FDA in germline BRCA-mutated metastatic breast cancer
1/15/2018 7:40:40 AM
AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) announced that the US Food and Drug Administration (FDA) has approved Lynparza (olaparib), for use in patients with deleterious or suspected deleterious germline BRCA -mutated (g BRCA m), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer …
Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent
Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent
1/12/2018 11:32:04 AM
Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States were performed at New York-Presbyterian Hospital/Columbia University Medical Center in New York City and the Piedmont Heart Institute in Atlanta.
Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs
Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs
1/11/2018 12:54:54 PM
Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ:  REGN ) will accelerate and expand investment for the clinical development of the PD-1 (programmed cell death protein 1) antibody cemiplimab in oncology and dupilumab in Type 2 allergic diseases.
Wiley Digital Archives Announces Debut Partnership with Royal College of Physicians to provide access to 500 years of medical history
Wiley Digital Archives Announces Debut Partnership with Royal College of Physicians to provide access to 500 years of medical history
1/11/2018 12:23:18 PM
John Wiley and Sons Inc., (NYSE:JW-A) (NYSE:JW-B) today announced that the Royal College of Physicians  (RCP) is the latest  Wiley Digital Archives  partner.
Infosys Prize for Six Top Researchers in Science and Humanities
Infosys Prize for Six Top Researchers in Science and Humanities
1/11/2018 4:47:18 AM
The Infosys Science Foundation (ISF) honored the winners of the Infosys Prize 2017 at an awards ceremony in Bengaluru and celebrated their inspiring journeys and contributions to science and research.
Novartis advances head-to-head superiority trials of Cosentyx® versus Humira®* and proposed biosimilar adalimumab**
Novartis advances head-to-head superiority trials of Cosentyx® versus Humira®* and proposed biosimilar adalimumab**
1/10/2018 1:57:04 PM
Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondylitis (AS).
Understanding Compounding Pharmacy with Two Medical Experts
Understanding Compounding Pharmacy with Two Medical Experts
1/10/2018 6:43:56 AM
Experts in integrative medicine Dr. Stephen Holt and Dr. Uzoma Nwosu presents a comprehensive review and an overview on the subject of pain control and medication in “Topical Pain Management.” Designed for medical professionals, “Topical Pain Management” tackles the complex topic of the use of analgesics, their formulae, and their side effects.
Triad Technique Developed in Anti-Aging Research
Triad Technique Developed in Anti-Aging Research
1/9/2018 10:59:04 AM
An innovative technique in the field of anti-aging medicine is offered in The Anti-Aging Triad, a book by distinguished physician and best-selling author Stephen Holt.
Erica Miller’s “Chronologically Gifted” - Free Download Tomorrow (01/08/2018)
Erica Miller’s “Chronologically Gifted” - Free Download Tomorrow (01/08/2018)
1/7/2018 6:00:00 AM
Best Seller Publishing announces the release of Dr. Erica Miller’s new book Chronologically Gifted: Aging with Gusto: A Practical Guide for Healthy Living to Age 123.” It will be available for free download in the Amazon Kindle Store on January 8th.
Study Links Asthma and Allergic Rhinitis with Cataracts
Study Links Asthma and Allergic Rhinitis with Cataracts
1/5/2018 10:52:41 AM
In a study that investigated the association between allergic diseases and ophthalmologic diseases in 14,776 adults, asthma and allergic rhinitis were each associated with a 50% increased likelihood of having cataracts.
ADHD increases the risk of sexually transmitted infection, but ADHD medications may reduce it
ADHD increases the risk of sexually transmitted infection, but ADHD medications may reduce it
1/5/2018 10:30:04 AM
Attention-deficit/hyperactivity disorder (ADHD) increases the risk of subsequent sexually transmitted infections (STIs) among adolescent and young adult populations by about three times,  reports a  study  published in the January 2018 issue of the  Journal of the American Academy of Child and Adolescent Psychiatry  (JAACAP).
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018
1/3/2018 12:48:43 PM
Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the first quarter of 2018 of $0.84 per share on the company’s common stock.
Novartis Kisqali® received FDA Breakthrough Therapy designation for initial endocrine-based treatment in premenopausal women with HR+/HER2- advanced breast cancer
Novartis Kisqali® received FDA Breakthrough Therapy designation for initial endocrine-based treatment in premenopausal women with HR+/HER2- advanced breast cancer
1/3/2018 12:37:30 PM
• Designation based on Phase III MONALEESA-7 results demonstrating superior efficacy of Kisqali in combination with oral endocrine therapy compared to oral endocrine therapy in pre- or perimenopausal women who received no prior endocrine therapy for advanced disease[1] • Treatment benefit with Kisqali combination therapy was consistent compared to the …
FDA permits marketing of device to treat diabetic foot ulcers
FDA permits marketing of device to treat diabetic foot ulcers
1/2/2018 11:51:35 AM
Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
Did you know that the pilot and co-pilot are not allowed to eat the same food? Five intriguing facts about safety on board
Did you know that the pilot and co-pilot are not allowed to eat the same food? Five intriguing facts about safety on board
12/27/2017 5:39:24 AM
1. What happens if lightning strikes an airplane?   Lightning can and does occasionally strike airplanes, but fortunately planes are designed to tolerate lightning strikes.

  • « Previous
  • 1
  • Next »